Immediate impact on Indian pharma exports unlikely: Pharmexcil chairman Namit Joshi
[ad_1] Pharmexcil chairman Namit Joshi. File | Photo Credit: Special Arrangement India’s pharma exporters body Pharmexcil does not anticipate any immediate impact of the 100% tariff on branded and patented pharmaceutical imports the U.S. President Donald Trump annnounced on September 25 (Thursday) that left the world trade already reeling under his other recent tariff decisions […]
Continue Reading